THRN: Bathi saben saham sajrone rolas wulan pungkasan Thorne HealthTech

Thorne HealthTech (THRN) earnings per share dynamics over the last 12 months are based on moderately cyclical demand for premium nutraceuticals. The value 0.38 shows the current metric value, confirming financial stability. Revenue is generated through biohacking and preventive medicine. Growth prospects rely on brand loyalty and the accuracy of diagnostic tests while controlling marketing expenses.

THRN Bathi saben saham sajroning taun lumaku Thorne HealthTech (04.07.2022 - 21.10.2023)

Rincian analitis lan laporan data perusahaan Thorne HealthTech Inc (THRN)

- rega saham lan target rega konsensus:

Rega saham Thorne HealthTech|THRN - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Nilai pasar Thorne HealthTech, Inc.|THRN - Total Nilai Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Thorne HealthTech|THRN - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku thorne.com|THRN - Total Aset Bisnis

- rincian utang lan likuiditas:

Total Utang marang Modal Thorne HealthTech|THRN - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Thorne|THRN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Thorne HealthTech, Inc.|THRN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Thorne HealthTech|Rasio cepet thorne.com

- data bathi lan kelipatan valuasi:

THRN - Bathi resik|Bathi sing dikarepake Thorne HealthTech|THRN - Rasio rega marang bathi|Prakiraan rega marang bathi Thorne HealthTech, Inc.|THRN - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Thorne HealthTech, Inc.|THRN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Thorne HealthTech|THRN - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan thorne.com|THRN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Thorne HealthTech

Analisis umum perusahaan:Thorne HealthTech (THRN)

This indicator is calculated as the ratio of total annual net income to the number of shares outstanding. This metric reflects the actual operational efficiency of the business, stripped of the impact of issuance volume. For Thorne HealthTech (THRN), logistics automation and the implementation of diagnostic algorithms directly influence profit scalability. The trend in fundamental net income per share TTM demonstrates the ability of robotization to reduce costs. A slowdown in the growth of this indicator amid high quotes signals a risk of asset overvaluation.

Perusahaan pesaing